Prostate International
Công bố khoa học tiêu biểu
Sắp xếp:
Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
Prostate International - Tập 10 Số 2 - Trang 75-79 - 2022
Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate
Prostate International - Tập 2 - Trang 90-96 - 2014
Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
Prostate International - Tập 2 - Trang 147-151 - 2014
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
Prostate International - Tập 8 - Trang 99-106 - 2020
Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation
Prostate International - Tập 4 - Trang 54-55 - 2016
Value of T1/T2-weighted magnetic resonance imaging registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization
Prostate International - Tập 3 - Trang 80-86 - 2015
Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review
Prostate International - Tập 10 - Trang 117-122 - 2022
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
Prostate International - Tập 10 - Trang 14-20 - 2022
Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy
Prostate International - Tập 11 - Trang 145-149 - 2023
Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure
Prostate International - Tập 11 - Trang 69-75 - 2023
Tổng số: 169
- 1
- 2
- 3
- 4
- 5
- 6
- 17